. Author manuscript; available in PMC: 2011 Jan 1.

Published in final edited form as: Pediatr Blood Cancer. 2010 Jan;54(1):47–54. doi: 10.1002/pbc.22267

Table I.

Neuroblastoma Patient Characteristics

Enrolled/Evaluable:		50/45

Median (range) Age [yrs]:		8 (2.5–17)

Male/Female:		27/23

Diagnosis:	Neuroblastoma	46
	Ganglioneuroblastoma	4

Prior Therapy:	≥ chemotherapy regimens	25
	<3 chemotherapy regimens	25
	¹³¹I MIBG	26
	Biologic Therapy	44
	HSCT	39
	Radiation Therapy	41

Disease Status at Enrollment:	Measurable	9
	Evaluable	33
	No Evidence of Disease	8

ABT-751 Dosing Schedule:	Daily × 7d every 21d	8
	Daily × 21d every 28d	9
	Expansion cohort	33

ABT-751 cycles: median (range)		4 (1–53)